Combatting Helicobacter pylori: A Focus on Nanomaterials
Xuanping Wang1, Xihui Felicia Chan2, Yuyo Go3
1Geriatric Department, Royal Victoria Hospital, Belfast, UK.
Helicobacter
|December 26, 2024
Summary
Nanomaterials show promise as non-antibiotic treatments against Helicobacter pylori (H. pylori) infections. Further research could lead to new strategies for eradicating H. pylori and combating antibiotic resistance.
Area of Science:
- Biomedical Engineering
- Materials Science
- Infectious Diseases
Background:
- Antibiotic resistance, particularly from Helicobacter pylori (H. pylori) infections, necessitates novel antimicrobial strategies.
- Nanomaterials present a promising avenue for developing non-antibiotic treatments against H. pylori.
Purpose of the Study:
- To review the progress of nanomaterials in non-antibiotic anti-H. pylori treatment strategies.
- To explore advancements in nanomaterial-based H. pylori targeting, stimuli-responsive release, and multifunctional platforms.
Main Methods:
- Review of metallic and nonmetallic nanoparticles, nanozymes, and multifunctional nanoplatforms.
- Analysis of nanomaterial integration with physical methods (light, heat, ultrasound, magnetism).
- Summary of research on direct H. pylori inhibition and targeted delivery.
Main Results:
- Metallic and nonmetallic nanoparticles, and nanozymes demonstrate direct inhibition of H. pylori growth.
- Nanomaterials enable targeted delivery and stimuli-responsive release in the stomach.
- Multifunctional nanoplatforms synergistically enhance H. pylori treatment when combined with physical methods.
Conclusions:
- Nanomaterials offer a viable alternative to antibiotics for H. pylori eradication.
- Continued research into nanoplatforms holds significant potential for combating H. pylori infections and antibiotic resistance.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
272
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
272
Peptic Ulcer Disease IV: Management
45
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
45


